Clinical Efficacy of Istradefylline (KW-6002) in Parkinson's Disease: A Randomized, Controlled StudyMIZUNO, Yoshikuni; HASEGAWA, Kazuko; KONDO, Tomoyoshi et al.Movement disorders. 2010, Vol 25, Num 10, pp 1437-1443, issn 0885-3185, 7 p.Article

Istradefylline, an adenosine A_2A receptor antagonist, for patients with Parkinson's Disease: A meta-analysisWANQIANG CHEN; HONGQUAN WANG; HONGTAO WEI et al.Journal of the neurological sciences. 2013, Vol 324, Num 1-2, pp 21-28, issn 0022-510X, 8 p.Article

Study of Istradefylline in Patients with Parkinson's Disease on Levodopa with Motor FluctuationsHAUSER, Robert A; SHULMAN, Lisa M; TRUGMAN, Joel M et al.Movement disorders. 2008, Vol 23, Num 15, pp 2177-2185, issn 0885-3185, 9 p.Article

A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson diseaseSTACY, M; SILVER, D; MENDIS, T et al.Neurology. 2008, Vol 70, Num 23, pp 2233-2240, issn 0028-3878, 8 p.Article

Adenosine A_2A receptor antagonists for Parkinson's disease : Rationale, therapeutic potential and clinical experienceHAUSER, Robert A; SCHWARZSCHILD, Michael A.Drugs & aging. 2005, Vol 22, Num 6, pp 471-482, issn 1170-229X, 12 p.Article

Adenosine A_2A Receptor Antagonist Istradefylline (KW-6002) Reduces Off' Time in Parkinson's Disease : A Double-Blind, Randomized, Multicenter Clinical Trial (6002-US-005)LEWITT, Peter A; GUTTMAN, M; TETRUD, James W et al.Annals of neurology. 2008, Vol 63, Num 3, pp 295-302, issn 0364-5134, 8 p.Article

Effectiveness and Tolerability of Istradefylline for the Treatment of Restless Legs Syndrome : An Exploratory Study in Five Female PatientsDECERCE, John; SMITH, Lisa F; GONZALEZ, Walter et al.Current therapeutic research. 2007, Vol 68, Num 5, pp 349-359, issn 0011-393X, 11 p.Article

Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenantPEREZ-LLORET, Santiago; MERELLO, Marcelo.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 8, pp 1097-1107, issn 1465-6566, 11 p.Article

Istradefylline: First Global ApprovalDUNGO, Rosselle; DEEKS, Emma d.Drugs (Basel). 2013, Vol 73, Num 8, pp 875-882, issn 0012-6667, 8 p.Article

EFFECTS OF THE ADENOSINE A_2A ANTAGONIST KW 6002 (ISTRADEFYLLINE) ON PIMOZIDE-INDUCED ORAL TREMOR AND STRIATAL c-Fos EXPRESSION: COMPARISONS WITH THE MUSCARINIC ANTAGONIST TROPICAMIDEBETZ, A. J; VONTELL, R; VALENTA, J et al.Neuroscience. 2009, Vol 163, Num 1, pp 97-108, issn 0306-4522, 12 p.Article